Postoperative Hypoxemia Increases the Risk of Anastomotic Leak After Radical Esophagectomy
1 other identifier
observational
2,500
1 country
6
Brief Summary
This study aims to determine whether postoperative hypoxia (arterial partial pressure of oxygen (PaO₂)\<80 mmHg) is an independent risk factor for anastomotic leakage after esophagectomy. The investigators conducted a retrospective analysis of cases from their center over the past five years, stratifying patients into Low Pa0₂ Group and Normal Pa0₂ Group based on postoperative oxygen levels and comparing the incidence of anastomotic leakage between the groups. The goal is to establish whether hypoxia is a causative risk factor and whether correcting it can reduce the risk of anastomotic leakage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2021
Longer than P75 for all trials
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedFirst Submitted
Initial submission to the registry
December 16, 2025
CompletedFirst Posted
Study publicly available on registry
December 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedJune 16, 2026
June 1, 2026
4.9 years
December 16, 2025
June 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Esophageal Anastomotic Leakage Rate
Anastomotic leak was confirmed by either barium swallow study, CT scan, or endoscopy, or was clinically considered in cases with obvious salivary secretion from the cervical anastomosis. The esophageal anastomotic leakage rate was calculated as (the number of patients with a confirmed anastomotic leakage / the total number of patients who underwent esophagectomy) × 100%.
From the date of surgery to 30 days postoperatively
Study Arms (2)
Low Pa02 Group
Patients were defined as belonging to the Low PaO₂ group if they exhibited at least one recorded instance of PaO₂ \<80 mmHg within the first postoperative week.
Normal PaO2 Group
Patients maintained a PaO₂ ≥80 mmHg throughout the first postoperative week.
Eligibility Criteria
This retrospective cohort study included patients diagnosed with esophageal carcinoma or benign esophageal tumors who required surgical resection of the lesion followed by esophageal reconstruction. All patients had at least one postoperative arterial blood gas analysis, and anastomotic healing was assessed via esophagram, CT scan, endoscopy, or typical clinical sign.
You may qualify if:
- Patients diagnosed with esophageal carcinoma or benign esophageal tumors
- Patients requiring surgical resection of the lesion with subsequent esophageal reconstruction
- Patients must have had at least one postoperative arterial blood gas analysis
- Patients must have routinely undergone at least one of the following for postoperative evaluation of the anastomosis: endoscopy, CT scan, or esophagram
You may not qualify if:
- Patients who did not require esophageal reconstruction
- Patients undergoing esophageal replacement with colon
- Patients with incomplete data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sun Yat-sen Universitylead
- Sichuan Cancer Hospital and Research Institutecollaborator
- Affiliated Hospital of North Sichuan Medical Collegecollaborator
- Hebei Medical University Fourth Hospitalcollaborator
- Affiliated Cancer Hospital of Shantou University Medical Collegecollaborator
- Shanghai Chest Hospitalcollaborator
Study Sites (6)
Department of Thoracic Surgery, Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510060, China
Cancer Hospital of Shantou University Medical College
Shantou, Guangdong, China
The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital
Shijiazhuang, Hebei, China
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, China
Sichuan Cancer Hospital
Chengdu, Sichuan, China
0817-2598459
Nanchong, Sichuan, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hong Yang, M.D.
Department of Thoracic Surgery, Sun Yat-sen University Cancer Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 16, 2025
First Posted
December 30, 2025
Study Start
January 1, 2021
Primary Completion
December 1, 2025
Study Completion (Estimated)
December 1, 2026
Last Updated
June 16, 2026
Record last verified: 2026-06